Clinical Trial Update: A Phase I Study to Assess the Safety and Immunogenicity of ChAd63 ME-TRAP - MVA ME-TRAP Heterologous Prime-boost Vaccination Co-administered With EPI Vaccines in Gambian Infants [Phase 1]

View source ↗

Summary

Phase 1 trial completed evaluating safety and immunogenicity of a heterologous ChAd63 ME-TRAP/MVA ME-TRAP malaria vaccine co-administered with EPI vaccines in G…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• ChAd63 ME-TRAP (ChAd63 ME-TRAP)
• MVA ME-TRAP (MVA ME-TRAP)

Snippet

Sponsor: University of Oxford | Conditions: Malaria | Phase 1 | Status: COMPLETED